May 14, 2020 / 12:23 PM / in 14 days

BRIEF-Constellation Pharmaceuticals Provides Update Of Preliminary Data For CPI-0610 In Three EHA Abstracts

May 14 (Reuters) - Constellation Pharmaceuticals Inc :

* CONSTELLATION PHARMACEUTICALS PROVIDES UPDATE OF PRELIMINARY DATA FOR CPI-0610 IN THREE EHA ABSTRACTS

* CONSTELLATION PHARMACEUTICALS INC - CONTINUED HIGH RATE OF SVR35 IN 1L PATIENTS: 72% AT 12 WEEKS AND 67% AT 24 WEEKS

* CONSTELLATION PHARMACEUTICALS INC - SVR35 RESPONSES AND TRANSFUSION DEPENDENCE CONVERSION OBSERVED IN 2L MONOTHERAPY PATIENTS

* CONSTELLATION PHARMACEUTICALS INC - IMPROVEMENT IN BONE MARROW FIBROSIS SEEN ACROSS TREATMENT ARMS

* CONSTELLATION PHARMACEUTICALS INC - CPI-0610 IN MANIFEST WAS GENERALLY WELL TOLERATED. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below